CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al
Kamburova, Elena G., Koenen, Hans J. M. P., Joosten, Irma, Hilbrands, Luuk B.Volume:
65
Language:
english
Journal:
Arthritis & Rheumatism
DOI:
10.1002/art.37871
Date:
April, 2013
File:
PDF, 105 KB
english, 2013